Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Correspondence:
View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dubinsky, R.
Right arrow Articles by Lai, S.-M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dubinsky, R.
Right arrow Articles by Lai, S.-M.
Related Collections
Right arrow All Cerebrovascular disease/Stroke
Right arrow Infarction
Right arrow All Clinical trials
NEUROLOGY 2006;66:1742-1744
© 2006 American Academy of Neurology


Brief Communications

Mortality of stroke patients treated with thrombolysis: Analysis of nationwide inpatient sample

Richard Dubinsky, MD, MPH and Sue-Min Lai, PhD

From the University of Kansas Medical Center, Departments of Neurology (R.D.) and Preventive Medicine and Public Health (S.-M.L.), Kansas City, KS.

Address correspondence and reprint requests to Dr. Richard Dubinsky, Department of Neurology, University of Kansas Medical Center, 3599 Rainbow Blvd., Mail Stop 2012, Kansas City, KS 66160; e-mail: rdubinsky{at}safetyresearch.com or rdubinsk{at}kumc.edu

The authors performed a retrospective cohort comparison using the Nationwide Inpatient Sample for 1999 through 2002 of acute ischemic stroke admissions. Mortality was compared based on the use of thrombolysis. Hospital mortality was significantly greater for the thrombolysis cohort (10.1% vs 5.8%) as was the rate of secondary intracranial hemorrhage (4.2% vs 0.4%). US community experience in the use of thrombolysis has higher rates of complications and mortality than in controlled clinical trials.


Disclosure: The authors report no conflicts of interest.

Presented in part at the annual meeting of the American Academy of Neurology, April 2005.

Received November 11, 2005. Accepted in final form February 22, 2006.




This article has been cited by other articles:


Home page
NeurologyHome page
A. Alshekhlee, Z. Hussain, B. Sultan, and B. Katirji
Guillain-Barre syndrome: Incidence and mortality rates in US hospitals
Neurology, April 29, 2008; 70(18): 1608 - 1613.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
T. Kurth, P. U. Heuschmann, A. M. Walker, K. Berger, M. L. Flaherty, B. Kissela, P. Khatri, R. M. Dubinsky, and S. M. Lai
Mortality of stroke patients treated with thrombolysis: Analysis of nationwide inpatient sample
Neurology, February 27, 2007; 68(9): 710 - 711.
[Full Text] [PDF]

Correspondence:

Read all Correspondence

Mortality of stroke patients treated with thrombolysis: Analysis of nationwide inpatient sample
Tobias Kurth, et al.
Neurology Online, 22 Sep 2006 [Full text]
Mortality of stroke patients treated with thrombolysis
Matthew L. Flaherty, et al.
Neurology Online, 22 Sep 2006 [Full text]
Reply from the Authors
Richard M. Dubinsky, et al.
Neurology Online, 22 Sep 2006 [Full text]



HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by AAN Enterprises, Inc.